//
Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials
The Use of Sex-Specific Factors in the Assessment of Women’s Cardiovascular Risk
A Review of the Role of Breast Arterial Calcification for Cardiovascular Risk Stratification in Women
Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a secondary analysis of the EMPA-REG OUTCOME trial
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?
CT Angiographic and Plaque Predictors of Functionally Significant Coronary Disease and Outcome Using Machine Learning
Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular DiseaseA Prespecified Analysis From the FOURIER Trial